XML 79 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
9 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net income (loss) $ 43,347 $ (21,204)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 125,719 116,738
Stock-based compensation 109,505 72,868
Non-cash interest expense 9,524 9,746
Non-cash restructuring and other expense   6,833
Deferred tax provision (35,727) (2,321)
Other 4,259 1,671
Changes in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable (3,679) (13,023)
Prepaid expenses and other assets (17,095) (4,869)
Accounts payable (9,999) (3,960)
Accrued expenses and other liabilities (9,950) (7,825)
Deferred revenue 43,603 30,044
Net cash provided by operating activities 259,507 184,698
Cash flows from investing activities:    
Capital expenditures (24,267) (16,284)
Payments for acquisitions, net of cash acquired (319,299) (155,882)
Payments for acquired technology (715) (14,850)
Payments for equity investment   (14,970)
Purchases of marketable securities (10,776)  
Proceeds from sales of marketable securities 6,650  
Change in restricted cash balances 17,184 (22,070)
Net cash used in investing activities (331,223) (224,056)
Cash flows from financing activities:    
Payments of debt and capital leases (5,864) (6,376)
Payments of other long-term liabilities (7,794) (7,319)
Proceeds on settlement of share-based derivatives, net 9,414 6,391
Excess tax benefits on employee equity awards 8,220  
Proceeds from issuance of common stock, net of issuance costs   12,350
Proceeds from issuance of common stock from employee stock plans 21,712 22,832
Cash used to net share settle employee equity awards (30,027) (18,040)
Net cash (used in) provided by financing activities (4,339) 9,838
Effects of exchange rate changes on cash and cash equivalents 6,406 (5,444)
Net decrease in cash and cash equivalents (69,649) (34,964)
Cash and cash equivalents at beginning of period 516,630 527,038
Cash and cash equivalents at end of period $ 446,981 $ 492,074